Interview with Fortunato Ciardiello, MD, PhD about the use of Vorinostat in patients with advanced pleural mesothelioma (VANTAGE 014): urgent need to identify new drugs to face peak of cases in 10 years. Interview by the European Society for Medical Oncology (ESMO).
Link to this comment:
All Comments (0)